Sheets Smith Wealth Management Buys 11,350 Shares of CVS Health Corporation $CVS

Sheets Smith Wealth Management increased its stake in CVS Health Corporation (NYSE:CVS) by 201.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,973 shares of the pharmacy operator’s stock after purchasing an additional 11,350 shares during the quarter. Sheets Smith Wealth Management’s holdings in CVS Health were worth $1,280,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Symmetry Partners LLC grew its holdings in shares of CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock worth $439,000 after acquiring an additional 141 shares during the period. Harbor Capital Advisors Inc. grew its stake in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares during the period. HF Advisory Group LLC increased its position in shares of CVS Health by 2.9% during the 3rd quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock valued at $393,000 after purchasing an additional 145 shares during the last quarter. FineMark National Bank & Trust lifted its stake in shares of CVS Health by 1.7% in the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after purchasing an additional 157 shares during the period. Finally, 1620 Investment Advisors Inc. boosted its holdings in shares of CVS Health by 6.1% in the third quarter. 1620 Investment Advisors Inc. now owns 2,736 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 157 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Up 1.3%

Shares of CVS opened at $79.06 on Friday. CVS Health Corporation has a 1 year low of $43.65 and a 1 year high of $85.15. The company has a 50 day simple moving average of $78.97 and a two-hundred day simple moving average of $72.79. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a market cap of $100.35 billion, a P/E ratio of 208.04, a price-to-earnings-growth ratio of 0.78 and a beta of 0.48.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CVS. TD Cowen increased their price target on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Truist Financial set a $100.00 target price on CVS Health in a research report on Wednesday, December 10th. Jefferies Financial Group upped their price target on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Cantor Fitzgerald reiterated an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.